Click for best price
Organ Transplant Immunosuppressant Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 5249.7 million
|
Forecast Market size by 2029 |
US$ 6500.7 million
|
| Growth Rate |
CAGR of 3.1% |
Number of Pages |
73 Pages |
Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
This report aims to provide a comprehensive presentation of the global market for Organ Transplant Immunosuppressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Immunosuppressant Drugs. This report contains market size and forecasts of Organ Transplant Immunosuppressant Drugs in global, including the following market information:
Global Organ Transplant Immunosuppressant Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Organ Transplant Immunosuppressant Drugs Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Organ Transplant Immunosuppressant Drugs companies in 2022 (%)
The global Organ Transplant Immunosuppressant Drugs market was valued at US$ 5249.7 million in 2022 and is projected to reach US$ 6500.7 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Organ Transplant Immunosuppressant Drugs include Roche, Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc. and Veloxis Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Organ Transplant Immunosuppressant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Organ Transplant Immunosuppressant Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, by Type, 2022 (%)
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids
Global Organ Transplant Immunosuppressant Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, by Application, 2022 (%)
Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant
Global Organ Transplant Immunosuppressant Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Organ Transplant Immunosuppressant Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ Transplant Immunosuppressant Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Organ Transplant Immunosuppressant Drugs revenues share in global market, 2022 (%)
Key companies Organ Transplant Immunosuppressant Drugs sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Organ Transplant Immunosuppressant Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Sanofi
Astellas Pharma, Inc.
GlaxoSmithKline plc
Novartis AG
Pfizer, Inc.
Veloxis Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Organ Transplant Immunosuppressant Drugs, market overview.
Chapter 2: Global Organ Transplant Immunosuppressant Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Organ Transplant Immunosuppressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organ Transplant Immunosuppressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Organ Transplant Immunosuppressant Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Organ Transplant Immunosuppressant Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 5249.7 million
|
| Forecast Market size by 2029 |
US$ 6500.7 million
|
| Growth Rate |
CAGR of 3.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Organ Transplant Immunosuppressant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Organ Transplant Immunosuppressant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Organ Transplant Immunosuppressant Drugs Overall Market Size
2.1 Global Organ Transplant Immunosuppressant Drugs Market Size: 2022 VS 2029
2.2 Global Organ Transplant Immunosuppressant Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Organ Transplant Immunosuppressant Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Organ Transplant Immunosuppressant Drugs Players in Global Market
3.2 Top Global Organ Transplant Immunosuppressant Drugs Companies Ranked by Revenue
3.3 Global Organ Transplant Immunosuppressant Drugs Revenue by Companies
3.4 Global Organ Transplant Immunosuppressant Drugs Sales by Companies
3.5 Global Organ Transplant Immunosuppressant Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Organ Transplant Immunosuppressant Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Players in Global Market
3.8.1 List of Global Tier 1 Organ Transplant Immunosuppressant Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Organ Transplant Immunosuppressant Drugs Market Size Markets, 2022 & 2029
4.1.2 Antibodies
4.1.3 Antiproliferative Agents
4.1.4 Calcineurin Inhibitors
4.1.5 mTOR Inhibitors
4.1.6 Steroids
4.2 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
4.2.1 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
4.2.2 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
4.2.3 By Type - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
4.3.1 By Type - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
4.3.2 By Type - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
4.3.3 By Type - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Organ Transplant Immunosuppressant Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Organ Transplant Immunosuppressant Drugs Market Size, 2022 & 2029
5.1.2 Bone Marrow Transplant
5.1.3 Heart Transplant
5.1.4 Kidney Transplant
5.1.5 Liver Transplant
5.1.6 Lung Transplant
5.2 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
5.2.1 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
5.2.2 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
5.2.3 By Application - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
5.3.1 By Application - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
5.3.2 By Application - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
5.3.3 By Application - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Organ Transplant Immunosuppressant Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Organ Transplant Immunosuppressant Drugs Market Size, 2022 & 2029
6.2 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue & Forecasts
6.2.1 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2023
6.2.2 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, 2024-2029
6.2.3 By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Organ Transplant Immunosuppressant Drugs Sales & Forecasts
6.3.1 By Region - Global Organ Transplant Immunosuppressant Drugs Sales, 2018-2023
6.3.2 By Region - Global Organ Transplant Immunosuppressant Drugs Sales, 2024-2029
6.3.3 By Region - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.4.2 By Country - North America Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.4.3 US Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.4.4 Canada Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.4.5 Mexico Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.5.3 Germany Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.4 France Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.5 U.K. Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.6 Italy Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.7 Russia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.5.9 Benelux Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.6.3 China Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.4 Japan Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.5 South Korea Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.6.7 India Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.7.2 By Country - South America Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.7.3 Brazil Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.7.4 Argentina Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, 2018-2029
6.8.3 Turkey Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.4 Israel Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
6.8.6 UAE Organ Transplant Immunosuppressant Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.1.4 Roche Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Astellas Pharma, Inc.
7.3.1 Astellas Pharma, Inc. Company Summary
7.3.2 Astellas Pharma, Inc. Business Overview
7.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma, Inc. Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Company Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer, Inc. Key News & Latest Developments
7.7 Veloxis Pharmaceuticals
7.7.1 Veloxis Pharmaceuticals Company Summary
7.7.2 Veloxis Pharmaceuticals Business Overview
7.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Major Product Offerings
7.7.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Veloxis Pharmaceuticals Key News & Latest Developments
8 Global Organ Transplant Immunosuppressant Drugs Production Capacity, Analysis
8.1 Global Organ Transplant Immunosuppressant Drugs Production Capacity, 2018-2029
8.2 Organ Transplant Immunosuppressant Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Organ Transplant Immunosuppressant Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Organ Transplant Immunosuppressant Drugs Supply Chain Analysis
10.1 Organ Transplant Immunosuppressant Drugs Industry Value Chain
10.2 Organ Transplant Immunosuppressant Drugs Upstream Market
10.3 Organ Transplant Immunosuppressant Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Organ Transplant Immunosuppressant Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Organ Transplant Immunosuppressant Drugs in Global Market
Table 2. Top Organ Transplant Immunosuppressant Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Organ Transplant Immunosuppressant Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Organ Transplant Immunosuppressant Drugs Sales by Companies, (K Doses), 2018-2023
Table 6. Global Organ Transplant Immunosuppressant Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Organ Transplant Immunosuppressant Drugs Price (2018-2023) & (USD/ Dose)
Table 8. Global Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 9. List of Global Tier 1 Organ Transplant Immunosuppressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Organ Transplant Immunosuppressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 15. By Type - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 16. By Application ? Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 20. By Application - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 21. By Region ? Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2018-2023
Table 25. By Region - Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), 2024-2029
Table 26. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 29. By Country - North America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 38. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 41. By Country - South America Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales, (K Doses), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Organ Transplant Immunosuppressant Drugs Product Offerings
Table 48. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Organ Transplant Immunosuppressant Drugs Product Offerings
Table 52. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Astellas Pharma, Inc. Company Summary
Table 55. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product Offerings
Table 56. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 57. Astellas Pharma, Inc. Key News & Latest Developments
Table 58. GlaxoSmithKline plc Company Summary
Table 59. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product Offerings
Table 60. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 61. GlaxoSmithKline plc Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Organ Transplant Immunosuppressant Drugs Product Offerings
Table 64. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Pfizer, Inc. Company Summary
Table 67. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product Offerings
Table 68. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 69. Pfizer, Inc. Key News & Latest Developments
Table 70. Veloxis Pharmaceuticals Company Summary
Table 71. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product Offerings
Table 72. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/ Dose) (2018-2023)
Table 73. Veloxis Pharmaceuticals Key News & Latest Developments
Table 74. Organ Transplant Immunosuppressant Drugs Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 75. Global Organ Transplant Immunosuppressant Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Organ Transplant Immunosuppressant Drugs Production by Region, 2018-2023 (K Doses)
Table 77. Global Organ Transplant Immunosuppressant Drugs Production by Region, 2024-2029 (K Doses)
Table 78. Organ Transplant Immunosuppressant Drugs Market Opportunities & Trends in Global Market
Table 79. Organ Transplant Immunosuppressant Drugs Market Drivers in Global Market
Table 80. Organ Transplant Immunosuppressant Drugs Market Restraints in Global Market
Table 81. Organ Transplant Immunosuppressant Drugs Raw Materials
Table 82. Organ Transplant Immunosuppressant Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Organ Transplant Immunosuppressant Drugs Downstream
Table 84. Organ Transplant Immunosuppressant Drugs Downstream Clients in Global Market
Table 85. Organ Transplant Immunosuppressant Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Segment by Type in 2022
Figure 2. Organ Transplant Immunosuppressant Drugs Segment by Application in 2022
Figure 3. Global Organ Transplant Immunosuppressant Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Organ Transplant Immunosuppressant Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Organ Transplant Immunosuppressant Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Organ Transplant Immunosuppressant Drugs Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Organ Transplant Immunosuppressant Drugs Revenue in 2022
Figure 9. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose), 2018-2029
Figure 13. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose), 2018-2029
Figure 17. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 23. US Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 28. Germany Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 37. China Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Organ Transplant Immunosuppressant Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Organ Transplant Immunosuppressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Organ Transplant Immunosuppressant Drugs Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Organ Transplant Immunosuppressant Drugs by Region, 2022 VS 2029
Figure 54. Organ Transplant Immunosuppressant Drugs Industry Value Chain
Figure 55. Marketing Channels
